Overall, this new pathologic paradigm supports the assumption that the risk of developing APOL1-associated kidney diseases is a function of the APOL1 expression levels in podocytes; and follows a recessive gain-of-function mode of inheritance [25]. The gene discussed is APOL1; the disease is kidney disorder.